Work

Antisperm Antibody Positivity and Semen Quality Phenotypes Among Infertile Men in Erbil, Kurdistan Region, Iraq

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Antisperm antibodies (ASA) are recognized as a potential immunological factor in male infertility; however, their prevalence and clinical correlates remain incompletely characterized in Middle Eastern populations. This study aimed to estimate the prevalence of clinically significant ASA positivity and investigate its associations with demographic, clinical, and semen characteristics among infertile men in Erbil, Kurdistan Region of Iraq. Methods: A multicenter retrospective cross-sectional study was conducted between July 2025 and March 2026 at urology and fertility centers in Erbil. A total of 465 infertile men were included after predefined data cleaning and MAR-test reclassification procedures. Demographic, clinical, and semen parameters were collected, and ASA status was assessed using the direct mixed antiglobulin reaction (MAR) test. Clinically significant positivity was defined as antibodies bound to ≥50% of motile spermatozoa. Associations between ASA status and participant characteristics were examined using bivariate and multivariable analyses. Additional exploratory analyses included k-means clustering of semen profiles and Random Forest machine-learning modelling to evaluate predictors of ASA positivity. Results: ASA positivity was identified in 53 of 465 participants, yielding a prevalence of 11.4% (95% CI: 8.7–14.7%). No significant associations were observed between ASA positivity and residence, smoking status, varicocele, infertility type, nutritional supplement use, sperm concentration, progressive motility, non-progressive motility, or sperm morphology (all p > 0.05). Men with secondary infertility demonstrated a modestly higher median ASA percentage than those with primary infertility; however, binary ASA positivity did not differ significantly between groups. Multivariable logistic regression showed limited explanatory capacity (AUC = 0.607), while a Random Forest classifier achieved only marginal discrimination on the test dataset (AUC = 0.567). Clustering analysis identified two distinct semen-quality phenotypes, but ASA prevalence did not differ significantly between clusters. Conclusions: Clinically significant ASA positivity was present in approximately one in nine infertile men attending participating centers in Erbil. Routine demographic, clinical, and semen characteristics were poor predictors of ASA status, and neither conventional statistical modelling nor machine-learning approaches reliably identified ASA-positive individuals. These findings suggest that ASA-associated infertility may not be adequately captured by standard infertility assessments alone and support the selective use of direct ASA testing within comprehensive male infertility evaluation. Larger prospective studies incorporating fertile controls, detailed reproductive histories, complementary antibody assays, and immunological biomarkers are warranted.
Source: Immuno
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,207
OpenAlex ID: W7220416012
FWCI: 3.202
Cites: 22
Cited by: 1
Related to: 10